
这个市场不适合进入,结论很明确:不是机会市场,而是被少数高辨识度产品撑住的窄门市场。 目前没有出现30~100+新品牌涌入的典型超饱和信号,但盈利结构已经偏紧,整体可识别盈利产品只有28.57%,而且真正能作为新进入参考的成功样本只有1个新品牌、1个新产品,样本太少,不能把它当成可复制的好市场。
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
不建议进入,这个市场已经接近/处于价格战和高门槛区,且不适合小商家。 目前样本里只有2个可判定产品,盈利率28.57%,但真正能作为新进入参考的只有1个新品牌成功案例;这不代表市场友好,反而说明可见赢家非常少,且市场几乎被旧品牌和成熟款占位。
Alternative solutions may pose a risk to your investment in certain markets.
这个市场不适合进入,结论很明确:当前只看到 5 个品牌里有 1 个新品牌、4 个老品牌,新品牌占比只有 20%,不是“大量新品牌涌入”的扩张期;但能盈利的样本只有 2 个,占比 28.57%,利润并不宽裕,而且目前最好的新品牌案例只有 1 个,样本太少,说明这是一个靠少数强样本撑起来的市场,不是适合盲目入场的市场。
Big Brand 视角:能作为标杆的老品牌是 Living247,单个 ASIN B0DFJ1SBMM,售价 $14.95,月销量 100,月收入 $149,500,利润率 18.3%,但只有 85 条评论,说明它不是靠海量评价堆出来的极端盘,反而更像成熟品牌用稳定供给和常规投放维持的结果;如果大品牌要做,预算至少要按单品早期投入约 $2,295 级别去准备,而且这还只是首月到前几个月的显性投入,不含研发、包装和认证。Small Business 视角:真正的新品牌成功样本是 RelaxaX 的 B0GMPH93ZF,售价 $15.65,月销量 100,月收入 $156,500,利润率 29.2%,早期投入约 $2,295.21,其中广告约 $516.19,58 条评论,属于真实小品牌可参考的正例;它的可复制点不是拼价格,而是做同类中的同模型切入、保持白帽推广、把定位放在轻量、易理解、快速成交的单品上。
这个市场目前不值得进入。 现有数据只看到 5 个品牌、1 个新品牌,表面上不像“30~100+ 新品牌涌入”的超饱和,但利润结构已经偏紧:全市场可识别利润产品只有 28.57% 为盈利,而新产品里虽然 100% 盈利,却只有 1 个样本,样本太小,不能证明市场真的适合持续进入。
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
![]() | B0GMPH93ZF | RelaxaX | 2026-04-09 | Yes | $15.65 | 100pcs | $1565.0 | 29.17% | $456.52 |
![]() | B0DFJ1SBMM | Living247 | 2024-08-28 | Yes | $14.95 | 100pcs | $1495.0 | 18.3% | $273.59 |
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
![]() | B0GMPH93ZF | RelaxaX | 2026-04-09 | Yes | $15.65 | 100pcs | $1565.0 | 29.17% | $456.52 |
这个市场现在不适合进入。 数据显示它已经接近或进入高竞争状态:已识别品牌只有5个,却只有1个新品牌,成功高度集中在少数产品上;同时可确认的整体盈利产品占比只有28.57%,说明大多数产品并不赚钱。对新品牌来说,真正能作为正面样本的只有 RelaxaX 的 B0GMPH93ZF:投入约 2,295.21 美元,月利润 456.52 美元,利润率 29.2%,近月月销100单、月营收1,565美元,属于“靠明显差异化功能+外观设计”才跑出来的案例。
What is the ratio of profitable products
What is the ratio of different brands owning all profitable new products
这不是一个值得进入的市场:表面上只有1个新品牌成功,但整体样本里可盈利产品仅28.57%,而且最近没有形成明显的新品牌扩张热度;这意味着现在不是“机会市场”,更像是被少数样本撑起来的窄门市场。 对于大品牌,能进但要靠明显更强的品牌力、预算和持续投放;对于小商家,当前没有足够多的真实成功案例支撑复制,贸然进入风险很高。
证据很直接:核心样本里只有一个新品牌 RelaxaX,ASIN B0GMPH93ZF,4.7分、58条评论、月销100、月营收1565美元、利润率29.2%,早期投入约2295.21美元,其中广告516.19美元;它是典型的白帽新上架成功案例,说明“单个样本能赚钱”,但不足以证明市场可复制。更关键的是,市场里可识别的盈利/亏损产品比例只有28.57%,换句话说,大多数产品并不赚钱;而且时间趋势里几乎看不到持续增长的新品牌涌入,2026年只捕捉到这一条成功新进入记录,没有形成30~100+新品牌涌入那种明确超饱和信号,但也没有足够强的上升势头来支持入场判断。
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2025/7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/4 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| 2026/5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |